首页 | 本学科首页   官方微博 | 高级检索  
     


BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas
Authors:Muhammad F Bari  Helen Brown  Andrew G Nicholson  Keith M Kerr  John R Gosney  William A Wallace  Irshad Soomro  Salli Muller  Danielle Peat  Jonathan D Moore  Lesley A Ward  Maxim B Freidin  Eric Lim  Manu Vatish  David R J Snead
Affiliation:1. Department of Pathology, Dow International Medical College, , Karachi, Pakistan;2. Department of Pathology, University Hospitals Coventry and Warwickshire NHS Trust, , Coventry, UK;3. Divisions of Reproduction and Metabolic and Vascular Health, Warwick Medical School, , Coventry, UK;4. Department of Life Sciences, University of Warwick, , Coventry, UK;5. Department of Histopathology, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, , London, UK;6. Department of Pathology, Aberdeen Royal Infirmary, , Aberdeen, UK;7. Department of Pathology, Royal Liverpool University Hospital, , Liverpool, UK;8. Department of Pathology, Royal Infirmary of Edinburgh, , Edinburgh, UK;9. Department of Pathology, Nottingham City Hospital, , Nottingham, UK;10. Department of Pathology, University Hospitals of Leicester, , Leicester, UK;11. Department of Histopathology, Norfolk and Norwich University Hospital, , Norwich, UK;12. Warwick Systems Biology Centre, University of Warwick, , Coventry, UK;13. Department of Thoracic Surgery, Royal Brompton Hospital, , London, UK;14. Nuffield Department of Obstetrics and Gynaecology, University of Oxford, , Oxford, UK
Abstract:
Keywords:BAI3  biomarkers  CDX2  gene expression profiling  immunohistochemistry  large‐cell neuroendocrine lung carcinoma  small‐cell lung carcinoma  VIL1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号